Nothing Ventured Podcast Primer - Hussein Kanji - partner at Hoxton Ventures - S01E20
Hussein is a partner at Hoxton Ventures. He currently represents Hoxton on the boards of Baseimmune, BeyondRisk, Biocortex, Biotx, DruidAI, Finesse, Fy!, Giraffe360, Kbox, Kitt, Luminary, Peptone, PillSorted, Raptor Supplies, Really Clever, Rensair, Replai, Replan, Skin Analytics, TourRadar and XYZ Reality, and serves as a board observer on Behavox and Karakuri. 👂 Listen to the Main Episode here - https://youtu.be/I7XM7vEymmY 🕒 Time stamps - 0:00 - Intro / Hussein's career to date. 14:23 - What is Hoxton Ventures and what is his role in it? 20:39 - What are 3 ventures Hussein is most excited about right now? 🔗 Hussein Kanji's links - LinkedIn - https://www.linkedin.com/in/hkanji/?originalSubdomain=uk Twitter - https://twitter.com/hkanji Web - https://www.hoxtonventures.com/people/hussein-kanji/
Audio is streamed directly from the publisher (pscrb.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Hussein is a partner at Hoxton Ventures. He currently represents Hoxton on the boards of Baseimmune, BeyondRisk, Biocortex, Biotx, DruidAI, Finesse, Fy!, Giraffe360, Kbox, Kitt, Luminary, Peptone, PillSorted, Raptor Supplies, Really Clever, Rensair, Replai, Replan, Skin Analytics, TourRadar and XYZ Reality, and serves as a board observer on Behavox and Karakuri.
👂 Listen to the Main Episode here - https://youtu.be/I7XM7vEymmY
🕒 Time stamps -
0:00 - Intro / Hussein's career to date.
14:23 - What is Hoxton Ventures and what is his role in it?
20:39 - What are 3 ventures Hussein is most excited about right now?
🔗 Hussein Kanji's links -
LinkedIn - https://www.linkedin.com/in/hkanji/?originalSubdomain=uk
Twitter - https://twitter.com/hkanji
Web - https://www.hoxtonventures.com/people/hussein-kanji/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.